Sign in
Taking peoplePhase 2

Iron given through a vein after heart surgery for iron-deficiency anemia

Tests iron through a vein versus placebo in anemic people after heart surgery.

Key facts

Who runs it
University Health Network, Toronto
Where
Canada3 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery
Status
Recruiting
Phase
Phase 2
People taking part
60 people, planned
Started
3 Apr 2025
Expected to end
Jun 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Monoferric Injectable Product
  • 0.9% sodium chloride solution
Record updated
10 February 2026

Who can take part

The trial is looking for adults with low iron, with or without anemia, who are having planned open heart surgery. It tests iron given into a vein after surgery against a placebo (a dummy treatment).

Age
Older than 18 years
Sex
All sexes
Disease stage
Low iron before surgery, with or without anemia (Hb <130 g/L). Planned, non-emergency open heart surgery.
Earlier treatment
Cannot have had iron given into a vein in the 6 weeks before joining.
Biomarker or test result
Any one of: ferritin ≤100 μg/l; or ferritin ≤ 300 μg/L and transferrin saturation ≤ 20%; or reticulocyte Hb content < 29 pg, where available.
Main reasons for not taking part
  • Special procedures such as heart pump insertion, thoracoabdominal aneurysm, complex adult congenital surgery or heart transplant
  • Allergy to the iron product, more than 2 food or drug allergic reactions, iron overload, or anemia not caused by low iron
  • Decompensated liver cirrhosis (MELD ≥ 19), active hepatitis or active infection
  • Unstable blood pressure needing support drugs, or active bleeding before surgery
  • Refusing blood products, known pregnancy, or being in another trial that may affect anemia or transfusion care
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Patients who are undergoing any non-emergency open cardiac surgery and who meet all following criteria:
  • Age greater than 18 years old
  • Preoperative iron-deficiency with or without anemia (defined as Hb <130 g/L) with any one of:; ferritin ≤100 μg/l; or; ferritin ≤ 300 μg/L and transferrin saturation ≤ 20%; or; reticulocyte Hb content < 29 pg, where available

Who cannot take part

  • enrolment in another interventional trial which may impact anemia or transfusion management (for example, a trial of hemostatic therapies, such as tranexamic acid)
  • receipt of intravenous iron at any point in the 6 weeks prior to randomization
  • specialized procedures (e.g., ventricular assist device insertion, thoracoabdominal aneurysm, complex adult congenital surgery and heart transplant)
  • established contraindications to IV iron:; hypersensitivity to the iron product; history of >2 food and/or drug allergic reactions (excluding drug intolerance); non-iron deficiency anemias such as myelodysplastic syndrome; history of iron overload or disturbances in use of iron such as hemochromatosis or hemosiderosis; decompensated liver cirrhosis (MELD ≥ 19) or active hepatitis; active infection
  • preoperative unstable hemodynamics defined as the requirement for vasopressors or inotropes, or active bleeding (as noted in the clinical record and/or defined as a requirement for red blood cell transfusion for ongoing clinical bleeding)
  • Patients who meet any of the following criteria are not eligible for the study:
  • refusal of blood products for religious or other reasons
  • known pregnancy
  • already enrolled in this trial

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Chronic iron deficiency anaemia or cardiac surgery

This trial is currently available in Canada.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

POAM is a multicenter, randomized, controlled, internal pilot trial, using a conventional, parallel group, two-armed design at 3 cardiac surgery centres in Canada. The study is designed to assess the feasibility of a future, definitive RCT investigating whether, in patients with chronic iron-deficiency anemia undergoing cardiac surgery, IV iron therapy in the postoperative period (initiated shortly after surgery, and repeated at 42 days after surgery, if needed) improves clinical outcomes (days alive and out of hospital at 90 days after surgery; DAOH-90) relative to placebo.

The 2 groups in the trial

  • Intervention GroupTreatment being tested

    Patients randomized to the IV iron group will receive 1000 mg ferric derisomaltose (Monoferric) diluted in 100 mL of 0.9 % sodium chloride solution, via intravenous infusion over 1 hour using an opaque IV bag and tubing for blinding.

    Treatment: Monoferric Injectable Product

  • Control groupPlacebo, for comparison

    Patients randomized to the placebo group will receive 100 mL of 0.9 % sodium chloride solution via intravenous infusion using an opaque IV bag and tubing for blinding.

    Treatment: 0.9% sodium chloride solution

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery: A Pilot, Multi-centre, Placebo-controlled Randomized Trial.
Plain-language title
Iron given through a vein after heart surgery for iron-deficiency anemiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06287619, who can take part
Publications
Record updated
10 February 2026